Pharmaceutical Preperations - Industry Analysis
Industry Analysis: Pharmaceutical Preparations
Macro and Micro Analysis
Macro & Micro Industry Analysis: Pharmaceuticals subgroup: Pharmaceutical preparations
The report analyses the macro and micro-environmental factors of the industrial group called “Manufacture of pharmaceutical preparations” with the standard industrial code of 21200, according to the most recent version of the UK Standard Industrial Classification (SIC) of 2007. (Office for National Statistics, 2007)
Although different classification models from the United Nations and the United States attribute different codes to this industry, they generally share the same definitions, when it comes to the areas associated with it. These include: manufacturing, processing and fabrication of drugs in pharmaceutical preparations for human use as well as veterinary usage. Most of the products are developed and finished in a form aimed for final consummation, as for example ampoules, capsules, ointments, tablets, solutions, medical powders, vials and suspensions. The industry focuses on the design of products for two essential lines; firstly, pharmaceutical preparations that are designed initially medical, dental as well as veterinary purposes and secondly, pharmaceutical preparations that are designed initially for public, namely common consumers. (United States Department of Labor, 2012)
The Pharmaceutical sector in an especially interesting one since it is basically one of the most rapid augmenting industries being worth several trillion dollars worldwide and influencing the health of more than 4.6 billion humans worldwide. It constitutes on average over more than 10% of the GDP of the most developed nations and therefore forms a large portion of not only these countries’ economies but also the entire world economy. (Sheth, 2010)
With a global population surpassing the 7 billion mark and a trend for further growth due to an ageing population with a higher life expectancy (on average 67.2
Macro and Micro Analysis
Macro & Micro Industry Analysis: Pharmaceuticals subgroup: Pharmaceutical preparations
The report analyses the macro and micro-environmental factors of the industrial group called “Manufacture of pharmaceutical preparations” with the standard industrial code of 21200, according to the most recent version of the UK Standard Industrial Classification (SIC) of 2007. (Office for National Statistics, 2007)
Although different classification models from the United Nations and the United States attribute different codes to this industry, they generally share the same definitions, when it comes to the areas associated with it. These include: manufacturing, processing and fabrication of drugs in pharmaceutical preparations for human use as well as veterinary usage. Most of the products are developed and finished in a form aimed for final consummation, as for example ampoules, capsules, ointments, tablets, solutions, medical powders, vials and suspensions. The industry focuses on the design of products for two essential lines; firstly, pharmaceutical preparations that are designed initially medical, dental as well as veterinary purposes and secondly, pharmaceutical preparations that are designed initially for public, namely common consumers. (United States Department of Labor, 2012)
The Pharmaceutical sector in an especially interesting one since it is basically one of the most rapid augmenting industries being worth several trillion dollars worldwide and influencing the health of more than 4.6 billion humans worldwide. It constitutes on average over more than 10% of the GDP of the most developed nations and therefore forms a large portion of not only these countries’ economies but also the entire world economy. (Sheth, 2010)
With a global population surpassing the 7 billion mark and a trend for further growth due to an ageing population with a higher life expectancy (on average 67.2
References: United Nations Statistics Division, (2012) International Industry Classification [Online] http://unstats.un.org/unsd/cr/registry/regcs.asp?Cl=27&Lg=1&Co=21 [accessed 27th December 2012] Sheth, K Central Intelligence Agency, (2012) Life Expectancy at Birth [online] https://www.cia.gov/library/publications/the-world-factbook/rankorder/2102rank.html [accessed 27th December 2012] ABPI, (2012) Global pharmaceutical industry and market European Commision, (2011) Overview of the EU’s pharmaceuticals sector. [online] http://trade.ec.europa.eu/doclib/docs/2012/january/tradoc_148988.pdf [accessed 2nd January 2013] Sloman, J., Hinde, K ABPI, (2011) Top world pharmaceutical corporations. [online] http://www.abpi.org.uk/industry-info/knowledge-hub/global-industry/Pages/pharmaceutical-companies.aspx [accessed 2nd January 2013] Pfizer (2012) Pfizer (2011) Annual Review and Financial Statements 2011. New York: Pfizer Inc. Novartis (2011) Annual Review and Financial Statements 2011. Basel: Novartis AG Novartis (2012) Merck & Co. (2012) About Us [Online] http://www.merck.com/about/home.html [accessed 28th December 2012] Merck & Co Sanofi (2012) Our Company [Online] http://en.sanofi.com/our_company/our_company.aspx [accessed 28th December 2012] Sanofi (2011) Annual review and Financial Statements 2011 AstraZeneca (2012) About Us [Online] http://www.astrazeneca.com/About-Us [accessed 28th December 2012] AstraZeneca (2011) Annual review and Financial Statements 2011 Findlay, M. (2009) What Does the Global Economic Downturn Mean to the Pharma Industry? [Online] http://www.frost.com/sublib/display-market-insight-top.do?id=155855105 [accessed 3rd January 2013] Pain, E Frost & Sullivan, 2008 360 Degree CEO Percpective of the Global Healthcare Industry. [Online] http://www.slideshare.net/pathross/global-pharmaceuticals-amp-biotechnology-industry [accessed 3rd January 2013] Eubusiness, (2012) Pharmaceuticals in the EU WHO, (2012) 10 facts on obesity. [Online] http://www.who.int/features/factfiles/obesity/en/ [accessed 3rd January 2013] Figures: Porter, M.E. (1980), Competitive Strategy: Techniques for Analyzing Industries and Competitors. 1st edn. New York: Free Press.